The Trump administration has the legal tools and political will to ban medication abortion nationwide. It's waiting until after the midterms to use them — a delay that reveals the policy's architects know exactly how unpopular it is.
A voting divide between young men and women has reached a scale with no modern precedent — and it is about to determine who controls Congress. Neither party has a strategy adequate to what is coming.
The Supreme Court temporarily blocked a Fifth Circuit ruling that would have ended mail-order mifepristone prescriptions. The order, signed by Samuel Alito, preserves access for now — but the legal architecture to eliminate medication abortion nationwide is still intact and moving forward.
ProPublica investigation reveals Florida hospitals used judges to force surgical births on women who wanted vaginal delivery — even when the medical justification was contested.
New data shows telehealth abortion prescriptions are replacing interstate travel for procedures, as digital networks quietly bypass state bans through shield laws and mail-order pharmacies.
The Title X program providing free reproductive healthcare to 2.3 million low-income Americans expires March 31 with no explanation from Congress, threatening a public health catastrophe.